Zhongchao Inc.
No SEC Form 4 filings for $ZCMD in the last 30 days.
See all $ZCMD insider activity →Zhongchao Inc. (NASDAQ: ZCMD) announced a 1-for-2 share consolidation, effective October 2, 2026. The company's Class A and B shares will be consolidated, reducing the total outstanding shares. The move aims to maintain its listing on the Nasdaq Capital Market. The consolidation was approved by shareholders and the board of directors in September 2026.
A healthcare sector roundup highlights biotech stock moves. Zhongchao (ZCMD) rose about 192% after a 1-for-3 reverse split for Nasdaq compliance. Lakewood-Amedex (LABT) gained about 83% on positive Nu-3 Phase 2-ready updates. Arrowhead (ARWR) jumped about 19% after SHASTA-3/4 topline results for Plozasiran. Other gainers included MSLE, DRIO, and LBRX.
Zhongchao Inc. (NASDAQ:ZCMD) shares jumped about 210% to $3.44 in after-hours Thursday after closing at $1.11. The move followed a 1-for-3 share consolidation effective Monday, approved by shareholders and the board to help maintain its Nasdaq listing. Trading volume rose to 23.99M vs 1.58M average; market cap is about $1.28M.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning ZCMD (Zhongchao Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent ZCMD coverage spans market movers, financial news and corporate actions.
The consolidation reduces share count by half, potentially tightening float and modestly supporting price.
Reverse-split compliance action is the immediate catalyst behind the outsized move, but it can also signal ongoing listing risk.
The after-hours surge is tied to the newly effective 1-for-3 reverse split, which can mechanically distort per-share price and liquidity/positioning.
Reverse split risk event that can affect liquidity, volatility, and near-term sentiment while preserving listing status.
Zhongchao Inc. (NASDAQ: ZCMD) is seeking shareholder approval for a proposal to implement reverse stock splits with ratios between 2:1 and 250:1 over three years, aiming to meet Nasdaq's minimum bid price requirements. The company's shares closed at $0.62 on November 25, 2025.
AlphAI scores every news story that mentions ZCMD with an AI model for sentiment and relevance, and aggregates insider trades from Zhongchao Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Zhongchao Inc. (NASDAQ: ZCMD) announced a 1-for-2 share consolidation, effective October 2, 2026. The company's Class A and B shares will be consolidated, reducing the total outstanding shares. The move aims to maintain its listing on the Nasdaq Capital Market. The consolidation was approved by shareholders and the board of directors in September 2026.
1 min readA healthcare sector roundup highlights biotech stock moves. Zhongchao (ZCMD) rose about 192% after a 1-for-3 reverse split for Nasdaq compliance. Lakewood-Amedex (LABT) gained about 83% on positive Nu-3 Phase 2-ready updates. Arrowhead (ARWR) jumped about 19% after SHASTA-3/4 topline results for Plozasiran. Other gainers included MSLE, DRIO, and LBRX.
3 min readZhongchao Inc. (NASDAQ:ZCMD) shares jumped about 210% to $3.44 in after-hours Thursday after closing at $1.11. The move followed a 1-for-3 share consolidation effective Monday, approved by shareholders and the board to help maintain its Nasdaq listing. Trading volume rose to 23.99M vs 1.58M average; market cap is about $1.28M.
3 min readZhongchao Inc. (ZCMD) said it will conduct a 1-for-31 share consolidation effective June 8, 2026, to stay compliant with Nasdaq Capital Market listing requirements. According to the company, 31 Class A (and 31 Class B) shares will be combined into one share, with fractional shares rounded up. It reported 79,685,696 Class A and 624,972 Class B shares outstanding before consolidation, versus about 2,570,507 and 20,161 after. The stock was down 16.02% at $0.030.
3 min readZhongchao Inc. (NASDAQ: ZCMD) is seeking shareholder approval for an amended proposal allowing its board broad authority to implement one or multiple reverse stock splits over three years, with a cumulative ratio between 2:1 and 250:1. This move is primarily aimed at satisfying Nasdaq's minimum bid price requirement, as the company's Class A shares closed at US$0.62 on November 25, 2025. The company has adjourned shareholder meetings to allow more time for consideration of these proposals, which also include a significant increase in authorized share capital.
3 min read